Russell Schundler Sells 14,738 Shares of Liquidia (NASDAQ:LQDA) Stock

Liquidia Corporation (NASDAQ:LQDA – Get Free Report) General Counsel Russell Schundler sold 14,738 shares of the stock in a transaction that occurred on Monday, July 13th. The shares were sold at an average price of $71.51, for a total value of $1,053,914.38. Following the completion of the sale, the general counsel directly owned 605,962 shares of the company’s stock, valued at $43,332,342.62. This represents a 2.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Liquidia Stock Performance

LQDA stock traded up $5.28 on Tuesday, reaching $76.49. 1,153,916 shares of the company were exchanged, compared to its average volume of 2,219,263. Liquidia Corporation has a 12 month low of $14.04 and a 12 month high of $82.96. The stock’s fifty day moving average price is $66.37 and its 200 day moving average price is $47.52. The firm has a market capitalization of $6.80 billion, a PE ratio of 546.40 and a beta of 0.55. The company has a debt-to-equity ratio of 1.18, a current ratio of 2.22 and a quick ratio of 2.03.

Get Liquidia alerts:

Liquidia (NASDAQ:LQDA – Get Free Report) last released its earnings results on Monday, May 11th. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.41 by $0.11. The firm had revenue of $132.87 million during the quarter, compared to analysts’ expectations of $119.44 million. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The firm’s revenue was up 4187.1% on a year-over-year basis. On average, research analysts anticipate that Liquidia Corporation will post 3.02 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. BTIG Research lifted their target price on Liquidia from $59.00 to $109.00 and gave the stock a “buy” rating in a research report on Monday, June 22nd. Oppenheimer set a $75.00 price objective on Liquidia in a research report on Friday, June 5th. Wells Fargo & Company boosted their price target on shares of Liquidia from $51.00 to $62.00 and gave the company an “overweight” rating in a report on Tuesday, May 12th. HC Wainwright raised their price objective on shares of Liquidia from $67.00 to $75.00 and gave the stock a “buy” rating in a report on Friday, June 5th. Finally, Needham & Company LLC lifted their target price on shares of Liquidia from $54.00 to $70.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Three analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $68.88.

Check Out Our Latest Stock Report on Liquidia

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Liquidia by 4.7% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company’s stock worth $556,000 after purchasing an additional 1,700 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in Liquidia by 10.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company’s stock valued at $12,703,000 after buying an additional 82,955 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Liquidia by 15.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company’s stock valued at $1,796,000 after buying an additional 16,022 shares during the last quarter. Creative Planning increased its stake in shares of Liquidia by 40.7% in the 2nd quarter. Creative Planning now owns 26,840 shares of the company’s stock valued at $334,000 after buying an additional 7,765 shares during the period. Finally, Legal & General Group Plc increased its stake in shares of Liquidia by 13.4% in the 2nd quarter. Legal & General Group Plc now owns 94,152 shares of the company’s stock valued at $1,174,000 after buying an additional 11,111 shares during the period. Institutional investors and hedge funds own 64.54% of the company’s stock.

About Liquidia

(Get Free Report)

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).

Featured Articles

• Five stocks we like better than Liquidia
• Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
• 3 Overlooked Energy ETFs Delivering Strong Returns and Income
• 3 Space Stocks That Could Outshine SpaceX After Its IPO
• JPMorgan’s Q2 Strength Gives the Stock Rally New Support

Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.